Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells

被引:3
|
作者
Rosado-Galindo, Heizel [1 ]
Domenech, Maribella [1 ,2 ]
机构
[1] Univ Puerto Rico Mayaguez, Bioengn Program, Mayaguez, PR 00682 USA
[2] Univ Puerto Rico Mayaguez, Dept Chem Engn, Mayaguez, PR 00682 USA
基金
美国国家卫生研究院;
关键词
topography; EGFR signaling; TNBC; secretome; stemness; PHASE-II; TARGETED THERAPY; GROWTH; PROLIFERATION; RESISTANCE; PROMOTES; OVEREXPRESSION; CHALLENGES; SIGNATURE; YAP/TAZ;
D O I
10.3389/fcell.2023.1124250
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Cancer stem cells (CSC), a major culprit of drug-resistant phenotypes and tumor relapse, represent less than 2 % of the bulk of TNBC cells, making them difficult to isolate, study, and thus, limiting our understanding of the pathogenesis of the disease. Current methods for CSC enrichment, such as 3D spheroid culture, genetic modification, and stem cell conditioning, are time consuming, expensive, and unsuitable for high-throughput assays. One way to address these limitations is to use topographical stimuli to enhance CSC populations in planar culture. Physical cues in the breast tumor microenvironment can influence cell behavior through changes in the mechanical properties of the extracellular matrix (ECM). In this study, we used topographical cues on polystyrene films to investigate their effect on the proteome and stemness of standard TNBC cell lines.Methods: The topographical polystyrene-based array was generated using razor printing and polishing methods. Proteome data were analyzed and enriched bioprocesses were identified using R software. Stemness was assessed measuring CD44, CD24 and ALDH markers using flow cytometry, immunofluorescence, detection assays, and further validated with mammosphere assay. EGF/EGFR expression and activity was evaluated using enzyme-linked immunosorbent assay (ELISA), immunofluorescence and antibody membrane array. A dose-response assay was performed to further investigate the effect of surface topography on the sensitivity of cells to the EGFR inhibitor.Results: Surface roughness enriched the CSC population and modulated epidermal growth factor receptor (EGFR) signaling activity in TNBC cells. Enhanced proliferation of MDA-MB-468 cells in roughness correlated with upregulation of the epidermal growth factor (EGF) ligand, which in turn corresponded with a 3-fold increase in the expression of EGFR and a 42% increase in its phosphorylation compared to standard smooth culture surfaces. The results also demonstrated that phenotypic changes associated with topographical (roughness) stimuli significantly decreased the drug sensitivity to the EGFR inhibitor gefitinib. In addition, the proportion of CD44+/CD24-/ALDH+ was enhanced on surface roughness in both MDA-MB-231 and MDA-MB-468 cell lines. We also demonstrated that YAP/TAZ activation decreased in a roughness-dependent manner, confirming the mechanosensing effect of the topographies on the oncogenic activity of the cells.Discussion: Overall, this study demonstrates the potential of surface roughness as a culture strategy to influence oncogenic activity in TNBC cells and enrich CSC populations in planar cultures. Such a culture strategy may benefit high-throughput screening studies seeking to identify compounds with broader tumor efficacy.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling
    Li, Xiyin
    Wang, Hairui
    Yang, Xing
    Wang, Xiaoqi
    Zhao, Lina
    Zou, Li
    Yang, Qin
    Hou, Zongliu
    Tan, Jing
    Zhang, Honglei
    Nie, Jianyun
    Jiao, Baowei
    CANCER LETTERS, 2021, 514 : 90 - 102
  • [2] Effects of Annona muricata Extract on Triple-Negative Breast Cancer Cells Mediated Through EGFR Signaling
    Alshaeri, Heba K.
    Alasmari, Moudi M.
    Natto, Zuhair S.
    Pino-Figueroa, Alejandro
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12519 - 12526
  • [3] Wnt signaling in triple-negative breast cancer
    Pohl, SO-G
    Brook, N.
    Agostino, M.
    Arfuso, F.
    Kumar, A. P.
    Dharmarajan, A.
    ONCOGENESIS, 2017, 6 : e310 - e310
  • [4] Wnt signaling in triple-negative breast cancer
    SÖ-G Pohl
    N Brook
    M Agostino
    F Arfuso
    A P Kumar
    A Dharmarajan
    Oncogenesis, 2017, 6 : e310 - e310
  • [5] The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
    Meyer, Aaron S.
    Miller, Miles A.
    Gertler, Frank B.
    Lauffenburger, Douglas A.
    SCIENCE SIGNALING, 2013, 6 (287)
  • [6] PHLPP1 depletion promotes tumorigenesis and stemness in triple-negative breast cancer cells through AKT signaling
    Haque, Md Anwarul
    Poullikkas, Thanasis
    Al-Amin Kaisar, F. M.
    Haque, Shariful
    Khatun, Mst Hajera
    Mamun, Al
    Khan, Alam
    MEDICAL ONCOLOGY, 2025, 42 (03)
  • [7] Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
    Yang, Fang
    Cao, Lulu
    Sun, Zijia
    Jin, Juan
    Fang, Hehui
    Zhang, Wenwen
    Guan, Xiaoxiang
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (12): : 1568 - 1577
  • [8] Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective
    Djamgoz, Mustafa B. A.
    STEM CELL REVIEWS AND REPORTS, 2025, 21 (02) : 337 - 350
  • [9] UCHL1 promotes cancer stemness in triple-negative breast cancer
    Tian, Chuntao
    Liu, Ying
    Liu, Yixiong
    Hu, Peizhen
    Xie, Shenglong
    Guo, Yu
    Wang, Hui
    Zhang, Zhiyong
    Du, Liuyang
    Lei, Binhua
    Wang, Yingping
    Xue, Lingfei
    Zhang, Dong
    Su, Jing
    Zhang, Xiaotong
    Zhang, Ruiwen
    Chen, Jiaohong
    Zhang, Xiangqian
    Chen, Ligang
    Li, Mingyang
    Jia, Qingge
    Song, Junyang
    Liu, Jin
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 240
  • [10] Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
    Linklater, Erik S.
    Tovar, Elizabeth A.
    Essenburg, Curt J.
    Turner, Lisa
    Madaj, Zachary
    Winn, Mary E.
    Melnik, Marianne K.
    Korkaya, Hasan
    Maroun, Christiane R.
    Christensen, James G.
    Steensma, Matthew R.
    Boerner, Julie L.
    Graveel, Carrie R.
    ONCOTARGET, 2016, 7 (43) : 69903 - 69915